Used as a key intermediate in the synthesis of fluorinated organic compounds, particularly in pharmaceuticals and agrochemicals. Its structure allows for the introduction of difluoroalkyl motifs, which can enhance metabolic stability and bioavailability in drug molecules. Commonly employed in Horner-Wadsworth-Emmons reactions to form fluorinated alkenes, which are valuable building blocks in medicinal chemistry. Also utilized in the development of novel enzyme inhibitors due to the electron-withdrawing nature of the difluoro group, influencing reactivity and binding characteristics.